LOS ANGELES—The “polypill” — a multi-drug pill — combining diuretic, ACE inhibitor, beta-blocker, statin and aspirin — brings even more benefit when it’s targeted at patients who are
Simon Thom
LOS ANGELES—The “polypill” — a multi-drug pill — combining diuretic, ACE inhibitor, beta-blocker, statin and aspirin — brings even more benefit when it’s targeted at patients who are at elevated coronary risk rather than being used as a general “insurance” policy for the over-fifties irrespective of risk. Professor Simon Thom from Imperial College in London tells Sarah Maxwell about his group’s findings presented to the American Heart Association 2012 Scientific Sessions.
LISTEN
[audio:https://www.audiomedica.com/podcasting/aha/121111SimonThomPODCASTLoRes.mp3]